Table 1

Patient and demographic characteristics according to treatment received

Treatment received, n (%)pTotal, n (%)
Surgery+RTSurgery alone
Age*0.96
 ≤65 years364 (42.0)1459 (42.1)1823 (42.1)
 >65 years503 (58.0)2009 (57.9)2512 (57.9)
Gender*0.53
  Male546 (63.0)2144 (61.8)2690 (62.1)
  Female321 (37.0)1324 (38.2)1645 (37.9)
COPD*0.48
  Yes363 (41.9)1498 (43.2)1861 (42.9)
  No504 (58.1)1970 (56.8)2474 (57.1)
Hypertension*0.63
  Yes417 (48.1)1636 (47.2)2053 (47.4)
  No450 (51.9)1832 (52.8)2282 (52.6)
Diabetes*0.39
  Yes224 (25.8)946 (27.3)1170 (27.0)
  No643 (74.2)2522 (72.7)3165 (73.0)
CAD*0.93
  Yes291 (33.6)1159 (33.4)1450 (33.4)
  No576 (66.4)2309 (66.6)2885 (66.6)
Liver cirrhosis*0.64
  Yes26 (3.0)94 (2.7)120 (2.8)
  No841 (97.0)3379 (97.3)4215 (97.2)
Tuberculosis*0.75
  Yes57 (6.6)218 (6.3)275 (6.3)
  No810 (93.4)3250 (93.7)4060 (93.7)
CHF*0.37
  Yes40 (4.6)186 (5.4)226 (5.2)
  No827 (95.4)3282 (94.6)4109 (94.8)
Hyperlipidemia*0.78
  Yes282 (32.5)1145 (33.0)1427 (32.9)
  No585 (67.5)2323 (67.0)2908 (67.1)
CKD*0.82
  Yes36 (4.2)150 (4.3)186 (4.3)
  No831 (95.8)3318 (95.7)4149 (95.7)
 Total867 (100)3468 (100)4335 (100)
  • All p values were calculated by using Chi-square test.

  • *Factors used for propensity-score match.

  • CAD, coronary artery heart disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; RT, radiotherapy.